Xvivo Perfusion AB (publ) (STO:XVIVO)
Sweden · Delayed Price · Currency is SEK 291.60
-2.80 (-0.95%)
May 25, 2026, 5:29 PM CET
Xvivo Perfusion AB Market Cap
Xvivo Perfusion AB has a market cap or net worth of 9.27 billion as of May 22, 2026. Its market cap has decreased by -6.72% in one year.
Market Cap
9.27B
Enterprise Value
9.09B
Revenue
834.53M
Ranking
n/a
PE Ratio
125.66
Stock Price
291.60
Market Cap Chart
Since October 8, 2012, Xvivo Perfusion AB's market cap has increased from 371.69M to 9.27B, an increase of 2,394.92%. That is a compound annual growth rate of 26.62%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 22, 2026 | 9.27B | 57.77% |
| Dec 30, 2025 | 5.88B | -61.84% |
| Dec 30, 2024 | 15.40B | 48.41% |
| Dec 29, 2023 | 10.38B | 90.12% |
| Dec 30, 2022 | 5.46B | -33.55% |
| Dec 30, 2021 | 8.22B | -8.90% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Getinge AB | 53.45B |
| Sectra AB | 53.33B |
| Elekta AB | 23.15B |
| Vitrolife AB | 14.46B |
| Nolato AB | 13.63B |
| MedCap AB | 8.49B |
| CellaVision AB | 2.91B |
| Devyser Diagnostics AB | 1.62B |